Overview

* Burcon fiscal Q2 revenue grows 783% yr/yr, driven by protein sales

* Burcon achieved first commercial production of canola and fava proteins

Outlook

* Burcon reaffirms 2025 revenue target of C$1-3 mln

* Company expects 2026 revenue to exceed C$10 mln

* Burcon sees continued revenue acceleration and margin expansion into 2026

Result Drivers

* COMMERCIAL PRODUCTION - Achieved first commercial production of Puratein® C canola protein and FavaPro™ fava protein

* CUSTOMER PIPELINE - Burcon advanced its robust customer pipeline with over 200 projects under evaluation

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 EPS -C$0.28

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)